<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2013-2-73-75</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-89</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORT</subject></subj-group></article-categories><title-group><article-title>Алгоритм лечения неоваскулярной глаукомы. Клинический случай</article-title><trans-title-group xml:lang="en"><trans-title>The treatment algorithm of neovascular glaucoma. Case report</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анисимова</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Anisimova,</surname><given-names>S. Yu.</given-names></name></name-alternatives><email xlink:type="simple">ophthalmo@mail.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анисимов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Anisimov</surname><given-names>S. I.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>10</day><month>07</month><year>2014</year></pub-date><volume>10</volume><issue>2</issue><fpage>73</fpage><lpage>75</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Анисимова С.Ю., Анисимов С.И., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Анисимова С.Ю., Анисимов С.И.</copyright-holder><copyright-holder xml:lang="en">Anisimova, S.Y., Anisimov S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/89">https://www.ophthalmojournal.com/opht/article/view/89</self-uri><abstract><p>Представлена последовательность действий при лечении случая неоваскулярной диабетической глаукомы с высоким ВГД и выраженной неоваскуляризацией радужки и угла передней камеры. При лечении сочетали панретинальную лазеркоагуляцию сетчатки, введение анти –VEGF препаратов и антиглаукомную операцию с имплантацией дренажа. Такой алгоритм позволяет избежать целого ряда геморрагических осложнений.</p></abstract><trans-abstract xml:lang="en"><p>The paper presents a sequence of operations for the treatment of diabetic neovascular glaucoma case with high IOP and marked iris neovascularization. In the treatment of combined panretinal laser photocoagulation of retina, injection of anti-VEGF and antiglaucomatoussurgery with implantation of drainage. This algorithm permits to avoid a number of hemorrhagic complications.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>неоваскулярная глаукома</kwd><kwd>панретинальная лазеркоагуляция</kwd><kwd>Луцентис</kwd><kwd>коллагеновый дренаж Ксенопласт</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neovascular glaucoma</kwd><kwd>panretinal laser coagulation</kwd><kwd>Lucentis</kwd><kwd>collagen Xenoplast drainage</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мазурина Н. К., Сдобникова С. В., Столяренко Г. Е. О расширении показаний к панретинальной лазеркоагуляции при пролиферативной диабетической ретинопатии. Пролиферативный синдром в офтальмологии. // Матер. 1 Междунар. научно-практ. конф. М., 2000. С. 60‑61.</mixed-citation><mixed-citation xml:lang="en">Мазурина Н. К., Сдобникова С. В., Столяренко Г. Е. О расширении показаний к панретинальной лазеркоагуляции при пролиферативной диабетической ретинопатии. Пролиферативный синдром в офтальмологии. // Матер. 1 Междунар. научно-практ. конф. М., 2000. С. 60‑61.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сургуч В. К., Еричев В. П. Ангиогенная терапия при неоваскулярной глаукоме // Глаукома. 2010. № 2. С. 55‑58.</mixed-citation><mixed-citation xml:lang="en">Сургуч В. К., Еричев В. П. Ангиогенная терапия при неоваскулярной глаукоме // Глаукома. 2010. № 2. С. 55‑58.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Davidorf F., Mouser J., Derick R. Rapid improvement of rubeosis iris from a single bevacizumab (Avastin) injection // Retina. 2006. V.26. P. 354‑356.</mixed-citation><mixed-citation xml:lang="en">Davidorf F., Mouser J., Derick R. Rapid improvement of rubeosis iris from a single bevacizumab (Avastin) injection // Retina. 2006. V.26. P. 354‑356.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Duke J., Brown G. The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction // Ophthalmology. 1989. V. 96. P. 92‑95.</mixed-citation><mixed-citation xml:lang="en">Duke J., Brown G. The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction // Ophthalmology. 1989. V. 96. P. 92‑95.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ehlers J., Spirn M., Lam A., et al. Combination intravitreal bevacizumab / panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma // Retina. 2008. V. 28. P. 696‑702.</mixed-citation><mixed-citation xml:lang="en">Ehlers J., Spirn M., Lam A., et al. Combination intravitreal bevacizumab / panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma // Retina. 2008. V. 28. P. 696‑702.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mermoud, A., Salmon S., Alexander P., et al. Molteno tube implantation for neovascular glaucoma. Long term results and factors influencing outcome // Ophthalmology. 1993. V. 100. P. 897‑902.</mixed-citation><mixed-citation xml:lang="en">Mermoud, A., Salmon S., Alexander P., et al. Molteno tube implantation for neovascular glaucoma. Long term results and factors influencing outcome // Ophthalmology. 1993. V. 100. P. 897‑902.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Molteno A., Fucik M., Demster A., et al. Otago glaucoma surgery outcome study, factors controlling capsule fibrosis around Molteno omplants with histological correlation // Ophthalmology. 2003. V.110. P. 2198‑2206.</mixed-citation><mixed-citation xml:lang="en">Molteno A., Fucik M., Demster A., et al. Otago glaucoma surgery outcome study, factors controlling capsule fibrosis around Molteno omplants with histological correlation // Ophthalmology. 2003. V.110. P. 2198‑2206.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wakabayashi T., Oshima Y., Sakaguchi H., et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases // Ophthalmology. 2008. V. 115. P. 1571‑1580</mixed-citation><mixed-citation xml:lang="en">Wakabayashi T., Oshima Y., Sakaguchi H., et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases // Ophthalmology. 2008. V. 115. P. 1571‑1580</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
